eISSN: 2391-6052
ISSN: 2353-3854
Alergologia Polska - Polish Journal of Allergology
Current issue Archive Manuscripts accepted About the journal Supplements Special issues Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
Search
Editorial Policies
Sarajevo Declaration on Integrity and Visibility of Scholarly Publications
1/2018
vol. 5
 
Share:
Send email
Share:
abstract:
Guidelines/recommendations

Hypersensitivity to biological drugs. Guidelines of the Section of Drug Hypersensitivity of the Polish Society of Allergology

Anna Bodzenta-Łukaszyk
,
Grażyna Bochenek
,
Grażyna Sławeta
,
Marita Nittner-Marszalska
,
Joanna Glück
,
Marek L. Kowalski
,
Joanna Makowska
,
Barbara Rymarczyk
,
Grzegorz Porębski

Alergologia Polska – Polish Journal of Allergology 2018; 5, 1: 45–50
DOI: https://doi.org/10.5114/pja.2018.74449
Online publish date: 2018/03/23
View full text Get citation
 
PlumX metrics:
Biological agents represent an emerging therapeutic option in current medicine. They are widely used in many clinical conditions including inflammatory and oncologic diseases. Although they are highly efficient in many cases, they also can produce significant adverse immunologic reactions due to hypersensitivity or their own biological activity. Here we present management strategies for hypersensitive reactions induced by biological agents. Skin testing is most common diagnostic tool for drug causality assessment. Desensitization protocols have been found to be safe and effective. Pharmacovigilance system and safety of biologic therapies require further extensive research.
keywords:

biological agents, drug hypersensitivity, adverse drug reactions, fusion proteins, monoclonal antibodies



Termedia
About us Contact
Copyright notice Privacy policy Advertising policy Contact us
Quick links
Journals Books eBooks Events
© 2024 Termedia Sp. z o.o.
Developed by Bentus.